Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical Inc (PRVCF)
OTHER OTC:PRVCF
PreveCeutical Medical (PRVCF) Stock Price & Analysis
37 Followers
PRVCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.03
Previous Close$0.02
Volume46.00K
Average Volume (3M)61.95K
Market Cap
$7.45M
Enterprise Value$12.43M
Total Cash (Recent Filing)C$1.68K
Total Debt (Recent Filing)C$3.78M
Price to Earnings (P/E)-27.1
Beta0.20
Next Earnings
May 01, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding535,303,359
10 Day Avg. Volume102,482
30 Day Avg. Volume61,948
Standard Deviation0.28
R-Squared0.02
Alpha0.00981
Financial Highlights & Ratios
Price to Book (P/B)-2.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-67.90
P/FCF Ratio105.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PreveCeutical Medical News
PremiumCompany Announcements
PreveCeutical Delays Financial Filings, Plans FundraiseOptions Prices
Currently, No data available
---
Ownership Overview
8.12%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.88% Public Companies and
Individual Investors
PRVCF FAQ
What was PreveCeutical Medical Inc’s price range in the past 12 months?
PreveCeutical Medical Inc lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is PreveCeutical Medical Inc’s market cap?
Currently, no data Available
When is PreveCeutical Medical Inc’s upcoming earnings report date?
PreveCeutical Medical Inc’s upcoming earnings report date is May 01, 2024 which is 6 days ago.
How were PreveCeutical Medical Inc’s earnings last quarter?
PreveCeutical Medical Inc released its earnings results on Nov 22, 2023. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is PreveCeutical Medical Inc overvalued?
According to Wall Street analysts PreveCeutical Medical Inc’s price is currently Overvalued.
Does PreveCeutical Medical Inc pay dividends?
PreveCeutical Medical Inc does not currently pay dividends.
What is PreveCeutical Medical Inc’s EPS estimate?
PreveCeutical Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PreveCeutical Medical Inc have?
PreveCeutical Medical Inc has 535,303,340 shares outstanding.
What happened to PreveCeutical Medical Inc’s price movement after its last earnings report?
PreveCeutical Medical Inc reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PreveCeutical Medical Inc?
Currently, no hedge funds are holding shares in PRVCF
---
PreveCeutical Medical Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
PreveCeutical Medical Inc
PreveCeutical Medical, Inc. engages in licensing, branding and marketing of nutraceutical and wellness products. Its product include cellb9 immune system booster, which is an oral solution. PreveCeutical Medical was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
---
Technical Analysis
PharmaCyte Biotech
―
CNBX Pharmaceuticals
―
Citius Pharmaceuticals
―
Medical Marijuana
―
---